Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: J Glaucoma. 2009 Aug;18(6):437–442. doi: 10.1097/IJG.0b013e31818c6f44

Table 2.

Average PERG amplitude, phase, noise, SNR and associated variability of recordings for healthy eyes (n = 66) and patient eyes (n = 90), both within- and between-trials.

Healthy eyes Patient Eyes
Within-trials Between-trials Within-trials Between-trials
Amplitude (µV) Mean (SD) 0.83 (0.27) 0.81 (0.26) 0.57 (0.25) 0.56 (0.23)
Noise (SD) 0.17 (0.08) N/A 0.19 (0.08) N/A
SNR (SD) 5.88 (3.02) N/A 3.75 (3.47) N/A
Sw ± 1.96se 0.08 ± 0.01 0.08 ± 0.02 0.06 ± 0.01 0.06 ± 0.01
CV% (SD) 11.5 (11.5) 9.9 (7.9) 12.2 (10.01) 11.2 (7.5)
ICC (95% CI) 0.91 (0.86, 0.94) 0.85 (0.77, 0.095) 0.92 (0.88, 0.95) 0.89 (0.83, 0.92)
Phase (π rad) Mean (SD) 1.82 (0.09) 1.81 (0.03) 1.81 (0.13) 1.81 (0.13)
Sw ± 1.96se 0.02 ± 0.006 0.03 ± 0.006 0.04 ± 0.008 0.04 ± 0.008
CV% (SD) 1.3 (1.5) 1.5 (1.4) 2.2 (2.2) 2.4 (2.2)
ICC (95% CI) 0.85 (0.77, 0.91) 0.88 (0.81, 0.92) 0.82 (0.74, 0.88) 0.83 (0.75, 0.88)